Literature DB >> 10657836

Hypothyroidism in primary hyperoxaluria type 1.

Y Frishberg1, S Feinstein, C Rinat, A Drukker.   

Abstract

We describe 4 patients, aged 3 months to 23 years, with end-stage renal disease and severe, symptomatic hypothyroidism. All 4 had primary hyperoxaluria type 1 (PH1) with diffuse tissue (kidneys, skeleton, eyes, heart) calcium-oxalate deposition, a condition known as oxalosis. The hypothyroidism responded to thyroid hormone replacement therapy. Clinical hypothyroidism within the framework of PH1/oxalosis was probably caused by thyroid tissue damage from an abundance of calcium oxalate. We recommend that thyroid function be monitored in patients with PH1 and oxalosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657836     DOI: 10.1016/s0022-3476(00)70112-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  Primary hyperoxalurias: diagnosis and treatment.

Authors:  Efrat Ben-Shalom; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2014-12-18       Impact factor: 3.714

Review 2.  Oxalate crystal deposition disease.

Authors:  Irama Maldonado; Vineet Prasad; Antonio J Reginato
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

3.  Long-term complications of systemic oxalosis in children-a retrospective single-center cohort study.

Authors:  Efrat Ben-Shalom; Ruth Cytter-Kuint; Choni Rinat; Rachel Becker-Cohen; Shimrit Tzvi-Behr; Jenny Goichberg; Vardit Peles; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2021-03-02       Impact factor: 3.714

Review 4.  Endocrine manifestations related to inherited metabolic diseases in adults.

Authors:  Marie-Christine Vantyghem; Dries Dobbelaere; Karine Mention; Jean-Louis Wemeau; Jean-Marie Saudubray; Claire Douillard
Journal:  Orphanet J Rare Dis       Date:  2012-01-28       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.